• Canagliflozin Remodels Mitochondria in Diabetic Kidneys

  2026-09-08

  A 2025 study shows that canagliflozin improves mitochondrial architecture and bioenergetic performance in proximal tubular cells from hypertensive–diabetic mice, with stronger functional effects in males than females. The findings extend interpretation of SGLT2 inhibitor activity beyond glucose lowering and provide a mechanistic framework for studying renal protection in diabetes and hypertension.

• Tolazoline for α2-Adrenergic Receptor Studies

  2026-09-08

  Tolazoline combines α2-adrenergic receptor antagonism with weaker ATP-sensitive potassium channel activity, making it useful for separating receptor-driven effects from β-cell and airway responses. This practical guide covers concentration selection, organ-bath and islet workflows, controls, and troubleshooting for reproducible pharmacological studies.

• Viperin Targets Coronavirus nsp8 to Block RTC Assembly

  2026-09-07

  A 2026 study identifies a ddhCTP-independent antiviral mechanism in which viperin binds coronavirus nsp8 and interferes with replication-transcription complex assembly and RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work maps critical interaction regions and suggests that conserved viperin–nsp8 recognition could inform broad-spectrum antiviral drug development.

• Oligomycin A and Mitochondrial Energy Failure

  2026-09-07

  Oligomycin A is a mitochondrial ATP synthase inhibitor for dissecting respiratory control, ATP demand, and ROS-linked cell death. This article connects controlled F0 inhibition with new insights into sodium-driven mitochondrial energy collapse and practical assay design.

• Canagliflozin in Renal Mitochondria Research

  2026-09-05

  Canagliflozin enables researchers to connect SGLT2 inhibition with renal glucose handling, mitochondrial remodeling, and bioenergetic function. This workflow emphasizes sex-aware animal design, matched vehicle controls, and complementary imaging and respiration assays for diabetes and kidney disease research.

• Silymarin: Practical Workflows for Bench Research

  2026-09-04

  Turn a chemically diverse milk thistle extract into a controlled research probe for redox biology, cancer, metabolism, and antiviral assays. This guide combines solvent handling, assay design, cross-validation, and troubleshooting for more interpretable Silymarin results.

• Palmitic acid: Practical Protocol and QC Guide

  2026-09-04

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid input for lipid metabolism, inflammation, insulin signaling, and palmitoylation-related workflows. This guide covers solvent selection, fresh preparation, quality checks, and limitations; the material is not appropriate as a direct aqueous stock or for prolonged storage in solution.

• Doxycycline Hyclate: MMP Inhibitor Workflows

  2026-09-03

  Build reproducible blood–brain barrier and neurovascular experiments with Doxycycline hyclate as a matrix metalloproteinases inhibitor. This practical guide translates arsenic-neurotoxicity findings into dosing, solubility, assay-selection, and troubleshooting decisions while distinguishing established evidence from exploratory applications.

• Prestained Protein Marker for SepM Western Blots

  2026-09-03

  Use a Triple color protein ladder to track SepM-related protein separation, confirm transfer, and distinguish broad molecular-weight regions in SDS-PAGE and Western blot workflows. Its EDTA-free format also supports Phosbind SDS-PAGE and fluorescent membrane imaging, making it useful for mutation-focused studies where sample handling and band interpretation must remain tightly controlled.

• UTP Solution for Reproducible RNA Workflows

  2026-09-02

  UTP Solution (100 mM) provides a high-purity, nuclease-free uridine nucleotide for in vitro transcription, RNA amplification, and siRNA production. This practical guide connects nucleotide handling and assay optimization with the TRIM66 olfactory-receptor study while clearly separating established findings from recommended workflow extensions.

• CHIR 99021 Trihydrochloride Organoid Workflow

  2026-09-02

  Build tunable intestinal organoid experiments with CHIR 99021 trihydrochloride, a selective GSK-3 inhibitor that connects pathway control with measurable changes in proliferation and differentiation. This guide translates recent organoid findings into practical dose-response designs, assay readouts, and troubleshooting decisions for stem cell and metabolic research.

• Nile Red in Autophagy and Lipid Droplet Assays

  2026-09-01

  Nile Red can do more than visualize intracellular lipid droplets: its dual fluorescence enables a framework for separating lipid storage phenotypes from autophagy-related mechanisms. This article explains how to use Nile Red in lipid metabolism research while interpreting findings from a key bifendate study without confusing droplet abundance with lipid flux.

• Canagliflozin and Proximal Tubule Mitochondria

  2026-09-01

  A 2025 study shows that canagliflozin does more than lower glucose in hypertensive–diabetic mice: it remodels proximal tubular mitochondria and improves male-cell bioenergetics. The findings connect SGLT2 inhibition with renal mitochondrial structure, function, and sex-dependent responses, while also defining important limits for translation beyond the mouse model.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-31

  A 2025 GeroScience study introduces a drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than conventional yeast backgrounds. The system identifies known and candidate TOR inhibitors while showing no TOR-dependent growth signal for canagliflozin, illustrating how pathway-focused screening can separate mTOR activity from unrelated pharmacology.

• Palmitic acid: Practical Protocol and QC Guide

  2026-08-31

  Palmitic acid (SKU N2456) provides a characterized solvent-based fatty acid input for controlled studies of lipid metabolism, insulin signaling, inflammation, and protein palmitoylation. It should not be added directly to aqueous systems or retained as a long-term solution; fresh preparation, matched vehicle controls, and documented reconstitution are required.

8658 records 1/578 page Next 12345 下5页 Last page